Literature DB >> 9613460

Aspirin after myocardial infarction: the importance of over-the-counter use.

S Hopper1, M Pierce.   

Abstract

BACKGROUND: Regular aspirin is beneficial after myocardial infarction (MI). Community-based surveys appear to show unsatisfactory uptake of aspirin after MI. This could be due to over-the-counter (OTC) use not being recorded. In a pilot study in one practice, 39% of patients on aspirin after MI used OTC preparations. In addition, women and older patients were less likely to use aspirin.
OBJECTIVES: We aimed to describe aspirin use following MI in general practices in West London, including regimens and OTC use, and to demonstrate any association between aspirin use and gender, age or social class.
METHODS: We used a postal questionnaire survey. The setting was a random sample of six general practices in Ealing, Hammersmith and Hounslow Health Authority who use Egton Medical Information Systems (EMIS) to store morbidity data. The subjects were registered patients with a history of MI. The main outcome measures were questionnaire data on aspirin use, regimen, OTC use, prescription charge exemption, age, gender, ethnic group and social class.
RESULTS: The prevalence of previously recorded MI in all age groups was 0.64%. The response rate was 89%. Regular aspirin was used by 80%. Of these, 22% use OTC aspirin. OTC use was significantly more common in those paying prescription charges. Aspirin use was not associated with gender, age or social class.
CONCLUSION: This study demonstrated a high uptake of aspirin among patients with previous MI as recorded by computer. OTC aspirin use was significant, and should be inquired about and recorded.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613460

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  8 in total

1.  Evidence for inequalities in the management of coronary heart disease in Scotland.

Authors:  C R Simpson; P C Hannaford; D Williams
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 2.  Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand.

Authors:  M E Seddon; M N Marshall; S M Campbell; M O Roland
Journal:  Qual Health Care       Date:  2001-09

3.  Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease.

Authors:  J Bedson; T Whitehurst; M Lewis; P Croft
Journal:  Br J Gen Pract       Date:  2001-12       Impact factor: 5.386

4.  Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care.

Authors:  Luis A García Rodríguez; Lucía Cea-Soriano; Elisa Martín-Merino; Saga Johansson
Journal:  BMJ       Date:  2011-07-19

5.  Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.

Authors:  Paul R Ward; Peter R Noyce; Antony S St Leger
Journal:  Int J Equity Health       Date:  2005-02-08

6.  Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease.

Authors:  Elisa Martín-Merino; Saga Johansson; Héctor Bueno; Luis A García Rodríguez
Journal:  Pragmat Obs Res       Date:  2012-03-15

7.  Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding.

Authors:  Colin John Crooks; Joe West; Timothy Richard Card
Journal:  Gastroenterology       Date:  2013-03-05       Impact factor: 22.682

8.  Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?

Authors:  Lucía Cea Soriano; Montse Soriano-Gabarró; Luis A García Rodríguez
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-12-13       Impact factor: 2.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.